Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers

Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 3

Abstract

The study examined the sensitivity of DPI in vitro performance to formulation and device changes. Rotahaler/Rotacaps was selected as the reference DPI drug product, and Aerolizer was selected as the test device. Since the test device was recognized to have much greater efficiency of dispersion, simple modifications to both formulation and device were made in an effort to provide a closer match to the in vitro performance of the reference product. The modifications included varying the drug and lactose particle sizes and/or lactose fine particle content in the test formulations, as well as lowering the specific resistance of the test device. These modifications were intended to address variables important for drug product performance for a defined experimental design and were not intended to mimic the extensive formulation and device design strategies that are employed in an industrial setting. Formulation and device modifications resulted in a modified test product that approached the reference product in the in vitro performance.

Authors and Affiliations

Wallace P. Adams, Sau L. Lee, Robert Plourde, Robert A. Lionberger, Craig M. Bertha, William H. Doub, Jean-Marc Bovet, Anthony J. Hickey

Keywords

Related Articles

Regional-Dependent Intestinal Permeability and BCS Classification: Elucidation of pH-Related Complexity in Rats Using Pseudoephedrine

Based on its lower Log P value relative to metoprolol, a marker for the low/high-permeability (Peff) class boundary, pseudoephedrine was provisionally classified as BCS low-permeability compound. On the other hand, follo...

Peptide-guided gene delivery

Although currently less efficient than their viral counter-parts, nonviral vectors are under intense investigation as a safer alternative for gene therapy. For successful delivery, the nonviral vector must be able to ove...

Targeting opioid receptor heterodimers: Strategies for screening and drug development

G-protein-coupled receptors are a major target for the development of new marketable drugs. A growing number of studies have shown that these receptors could bind to their ligands, signal, and be internalized as dimers....

Are Physiologically Based Pharmacokinetic Models Reporting the Right Cmax? Central Venous Versus Peripheral Sampling Site

The online version of this article (doi:10.1208/s12248-015-9796-7) contains supplementary material, which is available to authorized users.

Predicting Pediatric Age-Matched Weight and Body Mass Index

The online version of this article (doi:10.1208/s12248-014-9657-9) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681229
  • DOI  10.1208/s12248-012-9352-7
  • Views 66
  • Downloads 0

How To Cite

Wallace P. Adams, Sau L. Lee, Robert Plourde, Robert A. Lionberger, Craig M. Bertha, William H. Doub, Jean-Marc Bovet, Anthony J. Hickey (2012). Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers. The AAPS Journal, 14(3), -. https://europub.co.uk/articles/-A-681229